[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:raf1-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"RAF1 Gene",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06411821","Ulixertinib in People With Histiocytic Neoplasms",[11],"Phase 2","RECRUITING","2026-08-26T02:17:05.997056Z","2026-07-05T05:32:16.753306Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04923126","SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma",[19],"Phase 1\u002FPhase 2","2026-08-26T02:14:59.425132Z","2026-05-05T02:43:28.957186Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT04888936","Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies",[],"2026-08-26T02:17:59.904383Z","2026-05-13T02:55:06.274852Z"]